EADV 2026: Lebrikizumab improved hand and foot clearance, itch, and pain at 16 weeks versus placebo in a phase 3b atopic dermatitis trial.
News|Poll|April 10, 2015
An Enlarging Plaque
Author(s)George Han, MD, Adam Friedman, MD, FAAD
What figures into your differential of a slowly enlarging asymptomatic plaque, like the one on this child's hand?
Advertisement
A 5-year-old girl presents with an asymptomatic, slowly enlarging plaque on her hand with a slightly depressed hyperpigmented central portion and a distinct rim.
What does this look like to you?
Advertisement
Related to this article
The FDA has approved baricitinib for adolescents aged 12 and older with severe alopecia areata, marking the first systemic oral therapy cleared for this population.
Takeda’s oral TYK2 inhibitor showed rapid skin clearance in phase 3 psoriasis trials as FDA fast-tracks review; decision expected early 2027.
Advertisement
Advertisement
Trending on Patient Care Online
1
5 FDA Decisions for Primary Care to Know from September 2026
2
Fezolinetant Linked to 2.6 Fewer Nighttime Awakenings in Women With Menopausal VMS
3
Atrial Fibrillation Stroke Prevention: Expert Guidance for Primary Care Physicians
4
Switch to Oral Semaglutide Linked to 4.1% Weight Loss at 3 Months in New Study
5